CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
Junxin ChenGang LiuYizheng WuJianjun MaHongfei WuZiang XieShuai ChenYute YangShengyu WangPanyang ShenYifan FangShunwu FanShuying ShenXiang-Qian FangPublished in: Molecular cancer (2019)
CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to promote chromatin remodeling and thus enhances the transcriptional activity of β-catenin/LEF1 complex, which indicates that circMYO10 may be a potential therapeutic target for osteosarcoma treatment.